Relationship Between Antibiotic Consumption and Resistance in European Hospitals
|
|
- Osborn Chambers
- 5 years ago
- Views:
Transcription
1 Relationship Between Antibiotic Consumption and Resistance in European Hospitals Dominique L. Monnet National Center for Antimicrobials and Infection Control, Statens Serum Institut, Copenhague, Danemark
2 Food Animals Humans Humans STATENS SERUM INSTITUT The World (of Antimicrobial Resistance) According to Human Bacterial Pathogens and Their Habitat H R Pseudomonas aeruginosa R Acinetobacter baumannii MRSA R Salm. R Camp. R E. coli R Strep. pneumoniae R Haem. influenzae R S. aureus R E. coli R S. aureus le MONDe de la Résistance Intrinsèque et Acquise aux ANtibiotiques ;-).
3 Antimicrobial Consumption and Resistance: Examples from ARPAC European Hospitals, 21 % Fluoroquinolone-resistant Escherichia coli(%) n=112 R 2 =.7 % Imipenem-resistant Pseudomonas aeruginosa n=11 R 2 = Fluoroquinolone consumption (J1MA, DDD/1 bed-days) Carbapenem cosumption (J1DH, DDD/1 bed-days) Source: ARPAC, 24 (
4 Usefulness of Antimicrobial Resistance and Antimicrobial Use Data Comparison High level of resistance Low antimicrobial use Possible areas of improvement:. infection control. identif. of colonized patients upon admission. appropriate dosage (low dose). use of other antimicrobials Low level of resistance Low antimicrobial use % Resistant bacteria + median High level of resistance High antimicrobial use Antimicrobial Use (DDD/1, pt-days) Low level of resistance Relatively high antimicrobial use Area of improvement: antimicrobial use median Possible area of improvement: detection of resistance in the laboratory Possible explanation: resistant bacteria has not been introduced in setting Source : Int J Antimicrob Agents 2;15:91-11 (adapted from CDC/NNIS/ICARE Phase 1).
5 Gentamicin Use and %Gentamicin-Resistant Gram-Neg. Bacilli Isolates, Brussels, % Gentamicin-resistant gram-negative bacilli R =.9 p < Gentamicin use same year (g/year) Gentamicin use previous year (g/year) Source: Goossens H, et al. Lancet 1986;2:84.
6 Percent Ceftazidime-Resistant/Intermediate Gram-Negative Bacilli and Hospital Ceftazidime Use, Hospital Vega Baja, Spain, Yearly data 12 1 Monthly data (5-month moving average) Jan-91 Jan-92 Jan-93 Jan-94 Jan-95 Jan-96 Jan-97 Jan-98 Ceftazidime use (DDD/1, pt-days) Ceftazidime-resistant GNB (%) Source: Monnet DL, et al. Clin Microbiol Infect 21; 7(Suppl 5): ViResiST
7 Examples of Time Series Crude Death Rates for Infectious Diseases, USA, Dow Jones Industrial Average Source: Aiello AE & Larson EL. Lancet Infect Dis 22;2:13-1. Source: FT Investor Financial Times, 7/29/22.
8 Multivariate Time Series Analysis To assess relationships between a target (output) series and one or several explanatory (input) series Various types of models: transfer function (TF), polynomial distributed lag (PDL), etc. TF models: cross-correlation function (CCF) to identify time lags between series CCF Jan Jul-91 Jan-92 Jul-92 Jan-93 Jul-93 Jan-94 ErrUDA with ErrRes Jul-94 CCF Sources: Helfenstein U. Stat Meth Med Res 1996;5:3-22. Nº de retardos Haugh LD. J Am Stat Assoc 1976;71: Pankratz A. Forecasting with dynamic regression models. New York, NY: Wiley, Jan-95 Jul-95 Jan-96 Jul-96 Jan-97 Jul-97 Jan-98 Jul Límites confianza Coeficiente
9 Transfer Function Model for Percent Ceftazidime- Resistant/Intermediate Gram-Negative Bacilli Series (taking into account hospital ceftazidime use) Term Parameter (SE) T-ratio P-value Constant (.76) AR3.352 (.96) 3.68 <.1 AR5.265 (.98) 2.72 <.1 ULAG1.42 (.96) 4.34 <.1 R 2 =.44 Ceftazidime Use 1 month before Average delay = 1 month +1 DDD/1, patient-days = 6.5 days of treatment +.42 %R e.g. from R = 5% R = 5.42 % Source : López-Lozano JM, et al. Int J Antimicrob Agents 2;14:21-3. ViResiST
10 5-Month Moving Average Percent Amikacin- Resistant/Intermediate P. aeruginosa and Hospital Antimicrobial Use, Hospital Vega Baja, Spain, Months Source : Monnet DL, et al. Clin Microbiol Infect 21; 7(Suppl 5): Amikacin use (DDD/1, pt-dys) Amikacin-R P. aeruginosa (%) ViResiST
11 5-Month Moving Average Percent Amikacin- Resistant/Intermediate P. aeruginosa and Hospital Antimicrobial Use, Hospital Vega Baja, Spain, Gentamicin use (DDD/1, pt-dys) Tobramycin use (DDD/1, pt-days) Cefotaxime use (DDD/1, pt-dys) Ceftazidime use (DDD/1, pt-dys) Ceftriaxone (DDD/1, pt-dys) 1 Months Source : Monnet DL, et al. Clin Microbiol Infect 21; 7(Suppl 5): Amikacin use (DDD/1, pt-dys) Amikacin-R P. aeruginosa (%) ViResiST
12 Transfer Function Model for Percent Amikacin-Resistant Pseudomonas aeruginosa Series (taking into account aminoglycoside and 3rd-generation cephalosporin use) Term Order Parameter (SE) T-ratio P-value Constant (4.516) <.1 Amikacin (.391) 2.49 <.2 Gentamicin 7.42 (.153) 2.75 <.1 Cefotaxime (.112) 2.66 <.1 Cefotaxime (.11) 3.98 <.1 AR (.91) 3.24 <.1 Source : Monnet DL, et al. Clin Microbiol Infect 21; 7(Suppl 5): ViResiST
13 Co-Resistances in Amikacin-Resistant/Intermediate and Susceptible Pseudomonas aeruginosa Isolates, Hospital Vega Baja, Spain, Co-resistance Cross-resistance Amikacin-R/I Amikacin-S RR P-value no. (%) no. (%) Gentamicin-R/I 78 (97.5) 177 (17.5) 128. <.1 Cefotaxime-R/I 73 (91.3) 84 (83.) - NS Ceftriaxone-R/I* 4 (81.6) 361 (74.7) - NS Tobramycin-R/I 34 (42.5) 18 (1.8) 14.8 <.1 Ceftazidime-R/I 15 (18.8) 37 (3.7) 4.6 <.1 * only 55.3% of isolates were tested for susceptibility to ceftriaxone Source: Monnet DL, et al. Clin Microbiol Infect 21; 7(Suppl 5): ViResiST
14 %MRSA and Monthly Use of Macrolides, Third-Generation Cephalosporins and Fluoroquinolones, Aberdeen Royal Infirmary, 1/ /21 Explaining variable for monthly %MRSA Lag (months) Estimated coefficient %MRSA 1.42 Macrolide use 1,2,3.165 Third-generation cephalosporin use 4,5,6,7.29 Fluoroquinolone use 4,5.255 Constant R 2 =.92 Source: Monnet DL, et al. Emerg Infect Dis 24;1: ViResiST
15 5-Month Moving Average Percent Imipenem- Resistant/Intermediate P. aeruginosa and Hospital Imipenem Use, Hospital Vega Baja, Spain, Average delay = 1 month % Imipenem-resistant/intermediate Pseudomonas aeruginosa Jan -91 Jul -91 Jan DDD/1, pat-days +.4 %R Jul -92 Jan -93 Jul -93 Jan -94 Jul -94 Jan -95 Jul -95 Jan -96 Jul -96 Jan -97 Jul -97 Jan -98 Jul Hospital imipenem use (DDD/1, patient-days) Updated from: López-Lozano JM, et al. Int J Antimicrob Agents 2;14:21-3. ViResiST
16 %Carbapenem-Resistant Pseudomonas aeruginosa and Carbapenem Use in 4 Hospitals, STATENS SERUM INSTITUT Univ. Hospital, Ulm (D) Lepper et al. AAC 22;46: Univ. Hospital, Utah (USA) Samore MH, et al. Unpublished data. Average delay = -1 month Carbapenem-resistant P.aeruginosa(%) Jan -96 Jan -97 Jan -98 Jan -99 Jan - Jan Carbapenem use (DDD/1 pt-days) Average delay = -1 month Univ. Hospital, Antwerp (B) Goossens H, et al. Unpublished data. Centre Hosp. Mulhouse (F) Aujoulat O, Delarbre JM. ViResiST. Carbapenem-resistant P.aeruginosa(%) Jan -97 Jan -98 Jan -99 Jan - Jan -1 Jan Carbapenem use (DDD/1 pt-days) Average delay = -2 months Imipenem-resistant P.aeruginosa (%) Jan -99 Jan - Jan -1 Jan -2 Jan -3 Jan Carbapenem use (DDD/1 pt-days) Average delay = n.a. ViResiST
17 ACR Chart Source: Muller A, et al. (available free-of-charge, September 25)
18 Effects of reduction of quinolone use on antibiotic susceptibility in P. aeruginosa, Pittsburgh (PA), Source: Paterson DL, et al. 44th ICAAC, Washington (DC), 3-1/ , abstr. K-347.
19 Effect of Restricting Fluoroquinolones, ICU, Saint-Etienne (F), 2-22 Fluoroquinolone consumption (DDD/1, patient-days) Resistance (%) Fluoroquinolone consumption Ciprofloxacin-R P. aeruginosa Ofloxacin-R S. aureus MRSA Jan-Dec 2 Jan-Jun 21 Jul 21- Jun 22 Source: Aubert G, et al. J Hosp Infect 25;59:83-89.
20 STATENS Antibiotic SERUM Rotation INSTITUT and Development of Gram-Negative Antibiotic Resistance, Surgical ICU, Utrecht (NL), Proportion of patients treated (%) Levofloxacin Cefpirome 44 Pip/Tazo Levofloxacin 6 Cefpirome 1 Levofloxacin 1 Pip/Tazo 55 Source: van Loon HJ, et al. AJRCCM, in press (published online, October 29, 24).
21 Effect of Cycle Length.7 1 day cycles 9 day cycles 36 day cycles Fraction Resistant Cycling Time (days) Mixing Source: Bergstrom CT, et al. Proc Natl Acad Sci USA 24;11:
22 Areas for Future Research Adequation between studies at patient level and time series analyses? Are these relationships found in every hospital? More on the effect of interventions aiming at rationalizing antimicrobial prescriptions Short cycling vs. optimal mixing of prescriptions MRSA vs. antimicrobial consumption Outbreaks vs. endemic situations Interaction between infection control and antimicrobial consumption
23 3rd-gen. cephs-r Gram-neg. bact. Pan-Resistant Gram-Negative Bacilli Carbapenems ICU, Henry Dunant Hosp., Athens, Greece, Falagas ME, et al. BMC Infect Dis 25;5:24. Carbapenem-R, colistin-s only Gram-neg. bact. Prior colisitin use (days) ,31 6 No. cases 2 1 Colistin Jan. 21 Jan. 22 Jan. 23 Jan. 24 Pan-resistant Gram-neg. bact. Hosp. Clinico San Carlos, Madrid, 8/23-8/24: >2 pts with carbapenem-r, colistin-r P. aeruginosa Sánchez A, et al. Rev Esp Quimioterap 24;17:336-4.
24 It s a numbers game! Illustration: Prittie EJ. Philadeplphia, PA: JC Winston, 193.
ViResiST: its contribution to our knowledge of the relationship between antimicrobial use and resistance. Dominique L. Monnet
ViResiST: its contribution to our knowledge of the relationship between antimicrobial use and resistance Dominique L. Monnet About antibiotics... As soon as we use it, we loose it The more we use it, the
More informationThe International Collaborative Conference in Clinical Microbiology & Infectious Diseases
The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of
More informationAppropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationChallenge of time series models
Efficacy and efficiency of a restrictive antibiotic policy on MRSA in the intensive care unit N. Vernaz*, R. Aschbacher, B. Moser, S. Harbarth, P. Mian, P. Bonnabry, L. Pagani (Geneva, CH; Bolzano, IT)
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationHow is Ireland performing on antibiotic prescribing?
European Antibiotic Awareness Campaign 2016 November Webinar Series on Antibiotic Prescribing How is Ireland performing on antibiotic prescribing? Dr Rob Cunney National Clinical Lead HCAI AMR Clinical
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationAMR epidemiological situation: ECDC update
One Health Network on Antimicrobial Resistance (AMR) AMR epidemiological situation: ECDC update Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI)
More informationOutline. Antimicrobial resistance. Antimicrobial resistance in gram negative bacilli. % susceptibility 7/11/2010
Multi-Drug Resistant Organisms Is Combination Therapy the Way to Go? Sutthiporn Pattharachayakul, PharmD Prince of Songkhla University, Thailand Outline Prevalence of anti-microbial resistance in Acinetobacter
More informationAntibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units
NEW MICROBIOLOGICA, 34, 291-298, 2011 Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units Vladimíra Vojtová 1, Milan Kolář 2, Kristýna Hricová 2, Radek Uvízl 3, Jan Neiser
More information4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES
CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA BILLIE BARTEL, PHARMD, BCCCP APRIL 7 TH, 2017 DISCLOSURE I have had no financial relationship over the past 12 months with any commercial
More informationAntimicrobial Stewardship/Statewide Antibiogram. Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services
Antimicrobial Stewardship/Statewide Antibiogram Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda CMS and JCAHO
More informationWhat does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh
What does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh Disclosures Merck Research grant Clinical context of multiresistance Resistance to more classes of agents Less options
More informationAntimicrobial resistance and antimicrobial consumption in Europe
Antimicrobial resistance and antimicrobial consumption in Europe Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Programme Vilnius, 28 November
More informationMDR Acinetobacter baumannii. Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta
MDR Acinetobacter baumannii Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta 1 The Armageddon recipe Transmissible organism with prolonged environmental
More informationWhat is the problem? Latest data on antibiotic resistance
European Antibiotic Awareness Day 2009 What is the problem? Latest data on antibiotic resistance Zsuzsanna Jakab, ECDC Director Launch Seminar for EAAD Stockholm, 18 November 2009 Fluoroquinolone-resistant
More informationPrevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices
Prevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationContribution of pharmacokinetic and pharmacodynamic parameters of antibiotics in the treatment of resistant bacterial infections
Contribution of pharmacokinetic and pharmacodynamic parameters of antibiotics in the treatment of resistant bacterial infections Francois JEHL Laboratory of Clinical Microbiology University Hospital Strasbourg
More informationAerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune
Original article Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune Patil P, Joshi S, Bharadwaj R. Department of Microbiology, B.J. Medical College, Pune, India. Corresponding
More informationAntimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
More informationUpdate on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia. Po-Ren Hsueh. National Taiwan University Hospital
Update on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia Po-Ren Hsueh National Taiwan University Hospital Ventilator-associated Pneumonia Microbiological Report Sputum from a
More informationOriginal Articles. K A M S W Gunarathne 1, M Akbar 2, K Karunarathne 3, JRS de Silva 4. Sri Lanka Journal of Child Health, 2011; 40(4):
Original Articles Analysis of blood/tracheal culture results to assess common pathogens and pattern of antibiotic resistance at medical intensive care unit, Lady Ridgeway Hospital for Children K A M S
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationManagement of Hospital-acquired Pneumonia
Management of Hospital-acquired Pneumonia Adel Alothman, MB, FRCPC, FACP Asst. Professor, COM, KSAU-HS Head, Infectious Diseases, Department of Medicine King Abdulaziz Medical City Riyadh Saudi Arabia
More informationResponsible use of antibiotics
Responsible use of antibiotics Uga Dumpis MD, PhD Department of Infectious Diseases and Infection Control Pauls Stradiņs Clinical University Hospital Challenges in the hospitals Antibiotics are still effective
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More informationInitiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector
Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector Niels Frimodt-Møller Professor, MD DMSc Dept. of Clinical Microbiology Hvidovre Hospital, Copenhagen,
More informationNew Drugs for Bad Bugs- Statewide Antibiogram
New Drugs for Bad Bugs- Statewide Antibiogram Felicia Matthews, Pharm.D., BCPS Senior Consultant, Pharmacy Specialty BE MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda
More informationKonsequenzen für Bevölkerung und Gesundheitssysteme. Stephan Harbarth Infection Control Program
Konsequenzen für Bevölkerung und Gesundheitssysteme Stephan Harbarth Infection Control Program University of Geneva Hospitals Outline Introduction What data sources are available? AMR-associated outcomes
More informationSurveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital,
Original Article Vol. 28 No. 1 Surveillance of Antimicrobial Resistance:- Chaiwarith R, et al. 3 Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at
More informationAntimicrobial susceptibility
Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationAntimicrobial Stewardship Program: Local Experience
Antimicrobial Stewardship Program: Local Experience Dr. WU Tak Chiu Associate Consultant Division of Infectious Diseases Department of Medicine Queen Elizabeth Hospital 18th January 2011 QUEEN ELIZABETH
More informationHospital ID: 831. Bourguiba Hospital. Tertiary hospital
Global Point Prevalence Survey of Antimicrobial Consumption and Resistance in hospitals worldwide Hospital ID: 831 Habib Bourguiba Hospital Tertiary hospital Tunisia Point Prevalence Survey Habib 2017
More informationInt.J.Curr.Microbiol.App.Sci (2017) 6(3):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 3 (2017) pp. 891-895 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.603.104
More informationSurveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe
Surveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe Carl Suetens, ECDC Presented by Håkan Hanberger ecdc.europa.eu Message/Questions from C Suetens to Workshop 7, MIE2009
More informationMono- versus Bitherapy for Management of HAP/VAP in the ICU
Mono- versus Bitherapy for Management of HAP/VAP in the ICU Jean Chastre, www.reamedpitie.com Conflicts of interest: Consulting or Lecture fees: Nektar-Bayer, Pfizer, Brahms, Sanofi- Aventis, Janssen-Cilag,
More informationRecommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland
Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland A report by the Hospital Antimicrobial Stewardship Working Group, a subgroup of the
More informationPrevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase
More informationThe UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England
The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England Chief Medical Officer - Annual Report 2013 Antimicrobial resistance poses catastrophic
More informationSepsis is the most common cause of death in
ADDRESSING ANTIMICROBIAL RESISTANCE IN THE INTENSIVE CARE UNIT * John P. Quinn, MD ABSTRACT Two of the more common strategies for optimizing antimicrobial therapy in the intensive care unit (ICU) are antibiotic
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationAntimicrobial Pharmacodynamics
Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they
More informationRCH antibiotic susceptibility data
RCH antibiotic susceptibility data The following represent RCH antibiotic susceptibility data from 2008. This data is used to inform antibiotic guidelines used at RCH. The data includes all microbiological
More informationBacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India
ISSN: 2319-7706 Volume 4 Number 11 (2015) pp. 731-736 http://www.ijcmas.com Original Research Article Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching
More informationAn evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage
Journal of Antimicrobial Chemotherapy (1991) 27, Suppl. C, 1-7 An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage J. J. Muscato",
More informationAntimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report
Antimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated
More informationStratégie et action européennes
Résistance aux antibiotiques : une impasse thérapeutique? Implications nationales et internationales Stratégie et action européennes Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial
More informationNosocomial Infections: What Are the Unmet Needs
Nosocomial Infections: What Are the Unmet Needs Jean Chastre, MD Service de Réanimation Médicale Hôpital Pitié-Salpêtrière, AP-HP, Université Pierre et Marie Curie, Paris 6, France www.reamedpitie.com
More informationAntimicrobial consumption and impact on resistance
Antimicrobial consumption and impact on resistance 5th ESCMID School of Clinical Microbiology and Infectious Diseases Santander, Spain 10-16 June, 2006 Dr. Rafael Cantón Servicio de Microbiología. Hospital
More informationPrevalenceofAntimicrobialResistanceamongGramNegativeIsolatesinanAdultIntensiveCareUnitataTertiaryCareCenterinSaudiArabia
: K Interdisciplinary Volume 17 Issue 4 Version 1.0 Year 2017 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc. (USA) Online ISSN: 2249-4618 & Print ISSN:
More informationPreserving bacterial susceptibility Implementing Antimicrobial Stewardship Programs Debra A. Goff, Pharm.D., FCCP
Preserving bacterial susceptibility Implementing Antimicrobial Stewardship Programs Debra A. Goff, Pharm.D., FCCP Clinical Associate Professor Infectious Diseases Specialist The Ohio State University Medical
More informationStudy Protocol. Funding: German Center for Infection Research (TTU-HAARBI, Research Clinical Unit)
Effectiveness of antibiotic stewardship interventions in reducing the rate of colonization and infections due to antibiotic resistant bacteria and Clostridium difficile in hospital patients a systematic
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More informationIntroduction to Pharmacokinetics and Pharmacodynamics
Introduction to Pharmacokinetics and Pharmacodynamics Diane M. Cappelletty, Pharm.D. Assistant Professor of Pharmacy Practice Wayne State University August, 2001 Vocabulary Clearance Renal elimination:
More informationAberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015
Aberdeen Hospital Antibiotic Susceptibility Patterns For Commonly Isolated s For 2015 Services Laboratory Microbiology Department Aberdeen Hospital Nova Scotia Health Authority 835 East River Road New
More informationActive Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply.
Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted
More informationLack of Change in Susceptibility of Pseudomonas aeruginosa in a Pediatric Hospital Despite Marked Changes in Antibiotic Utilization
Infect Dis Ther (2014) 3:55 59 DOI 10.1007/s40121-014-0028-8 BRIEF REPORT Lack of Change in Susceptibility of Pseudomonas aeruginosa in a Pediatric Hospital Despite Marked Changes in Antibiotic Utilization
More informationSt. Joseph s General Hospital Vegreville. and. Mary Immaculate Care Centre. Antimicrobial Stewardship Report
St. Joseph s General Hospital Vegreville and Mary Immaculate Care Centre Antimicrobial Stewardship Report January to June 217 Introduction Antibiotics are among the most commonly prescribed medications
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union November 2012 Highlights on antibiotic consumption Antibiotic use is one of the main factors responsible for the development and
More informationThe challenge of Antibiotic Resistance - with special emphasis on the situation in resource constrained settings. Andreas Heddini, MD, PhD
The challenge of Antibiotic Resistance - with special emphasis on the situation in resource constrained settings Andreas Heddini, MD, PhD A Global Challenge Antibiotics are losing their effectiveness at
More informationReceived: February 29, 2008 Revised: July 22, 2008 Accepted: August 4, 2008
J Microbiol Immunol Infect. 29;42:317-323 In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections at a medical center
More informationAvailable online at ISSN No:
Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(4): 36-42 Comparative Evaluation of In-Vitro Doripenem Susceptibility with Other
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationAAC Accepts, published online ahead of print on 7 January 2008 Antimicrob. Agents Chemother. doi: /aac
AAC Accepts, published online ahead of print on January 00 Antimicrob. Agents Chemother. doi:./aac.0-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationSummary of the latest data on antibiotic resistance in the European Union
Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network
More informationMeasurement of Antimicrobial Drug Use. Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS DASON Liaison Pharmacist
Measurement of Antimicrobial Drug Use Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS DASON Liaison Pharmacist Defined Daily Dose Target Audience: Administrators and Epidemiologists Standardized definition
More informationAntimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013
Antimicrobial Resistance Surveillance from sentinel public s, South Africa, 213 Authors: Olga Perovic 1,2, Melony Fortuin-de Smidt 1, and Verushka Chetty 1 1 National Institute for Communicable Diseases
More informationRelationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae
Journal of Antimicrobial Chemotherapy (2004) 54, 173 177 DOI: 10.1093/jac/dkh282 Advance Access publication 18 May 2004 Relationship between ceftriaxone use and resistance to third-generation cephalosporins
More information(DRAFT) RECOMMENDATIONS FOR THE CONTROL OF MULTI-DRUG RESISTANT GRAM-NEGATIVES: CARBAPENEM RESISTANT ENTEROBACTERIACEAE
(DRAFT) RECOMMENDATIONS FOR THE CONTROL OF MULTI-DRUG RESISTANT GRAM-NEGATIVES: CARBAPENEM RESISTANT ENTEROBACTERIACEAE John Ferguson (Hunter New England, NSW) on behalf of MRGN Task Force Acknowledgement
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationSurveillance and Correlation of Antibiotic Prescription and Resistance of Gram-Negative Bacteria in Singaporean Hospitals
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Mar. 2010, p. 1173 1178 Vol. 54, No. 3 0066-4804/10/$12.00 doi:10.1128/aac.01076-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. Surveillance
More informationSurgical infection ผ.ศ. น.พ. กำธร มำลำธรรม หน วยโรคต ดเช อ ภำคว ชำอำย รศำสตร คณะแพทยศำสตร โรงพยำบำลรำมำธ บด
Surgical infection ผ.ศ. น.พ. กำธร มำลำธรรม หน วยโรคต ดเช อ ภำคว ชำอำย รศำสตร คณะแพทยศำสตร โรงพยำบำลรำมำธ บด 1 Scope Surgical prophylaxis: Pharmacologic approach to prevent SSI Antimicrobial therapy for
More informationPathogens and Antibiotic Sensitivities in Post- Phacoemulsification Endophthalmitis, Kaiser Permanente, California,
Pathogens and Antibiotic Sensitivities in Post- Phacoemulsification Endophthalmitis, Kaiser Permanente, California, 2007-2012 Geraldine R. Slean, MD, MS 1 ; Neal H. Shorstein, MD 2 ; Liyan Liu, MD, MS
More informationHosted by the Infection Prevention Society A Webber Training Teleclass
Broadcast Live From the Annual Conference of the Infection Prevention Society www.ips.uk.net The only drugs that are: Gary French Guy s & St Thomas Hospital & King s College, London Not directed against
More informationDoes Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?
Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs? John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control and
More informationWitchcraft for Gram negatives
Witchcraft for Gram negatives Dr Subramanian S MD DNB MNAMS AB (Medicine, Infect Dis) Infectious Diseases Consultant Global Health City, Chennai www.asksubra.com Drug resistance follows the drug like a
More informationRISK FACTORS AND CLINICAL OUTCOMES OF MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII BACTEREMIA AT A UNIVERSITY HOSPITAL IN THAILAND
RISK FACTORS AND CLINICAL OUTCOMES OF MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII BACTEREMIA AT A UNIVERSITY HOSPITAL IN THAILAND Siriluck Anunnatsiri 1 and Pantipa Tonsawan 2 1 Division of Infectious
More informationWhy should we care about multi-resistant bacteria? Clinical impact and
Why should we care about multi-resistant bacteria? Clinical impact and public health implications Prof. Stephan Harbarth Infection Control Program Geneva, Switzerland and Ebola (in 2014/2015) Increased
More information2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
More informationImpact of the pharmacist on a multidisciplinary team in an antimicrobial stewardship program: a quasi-experimental study
Int J Clin harm (2012) 34:290 294 DOI 10.1007/s11096-012-9621-7 SHORT RESEARCH REORT Impact of the pharmacist on a multidisciplinary team in an antimicrobial stewardship program: a quasi-experimental study
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More informationDetection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from a Tertiary Care Centre, Bengaluru, India
ISSN: 2319-7706 Volume 4 Number 12 (2015) pp. 578-583 http://www.ijcmas.com Original Research Article Detection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from
More information2016 Antibiotic Susceptibility Report
Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates
More informationQuelle politique antibiotique pour l Europe? Dominique L. Monnet
Quelle politique antibiotique pour l Europe? Dominique L. Monnet National Center for Antimicrobials & Infection Control Statens Serum Institut, Copenhagen, Denmark Opinion of the Section for Protection
More informationCONSUMPTION OF ANTIMICROBIAL DRUGS AND ANTIBIOTIC RESISTANCE IN PROBLEMATIC FOR HOSPITAL INFECTIOUS PATHOLOGY BACTERIA
Trakia Journal of Sciences, No 4, pp 338-342, 2013 Copyright 2013 Trakia University Available online at: http://www.uni-sz.bg ISSN 1313-7050 (print) ISSN 1313-3551 (online) Original Contribution CONSUMPTION
More informationFighting MDR Pathogens in the ICU
Fighting MDR Pathogens in the ICU Dr. Murat Akova Hacettepe University School of Medicine, Department of Infectious Diseases, Ankara, Turkey 1 50.000 deaths each year in US and Europe due to antimicrobial
More informationAntibiotic Stewardship in the Hospital Setting
Antibiotic Stewardship in the Hospital Setting G. Evans, MD FRCPC Medical Director, Infection Prevention & Control Kingston General Hospital & Hotel Dieu Hospital EOPIC September 26, 2012 Stewardship stew-ard-ship
More information2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital
2010 ANTIBIOGRAM University of Alberta Hospital and the Stollery Children s Hospital Medical Microbiology Department of Laboratory Medicine and Pathology Table of Contents Page Introduction..... 2 Antibiogram
More informationMultidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?
Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them? Roberta B. Carey, PhD Centers for Disease Control and Prevention Division of Healthcare Quality Promotion Why worry? MDROs Clinical
More information1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection
Surveillance, Outbreaks, and Reportable Diseases, Oh My! Assisted Living Facility, Nursing Home and Surveyor Infection Prevention Training February 2015 A.C. Burke, MA, CIC Health Care-Associated Infection
More informationMichael Hombach*, Guido V. Bloemberg and Erik C. Böttger
J Antimicrob Chemother 2012; 67: 622 632 doi:10.1093/jac/dkr524 Advance Access publication 13 December 2011 Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011
More informationGovernance e sostenibilità nell antibioticoterapia. Anna Maria Cattelan UOC Malattie Infettive Azienda Ospedaliera Universitaria Padova
Governance e sostenibilità nell antibioticoterapia Anna Maria Cattelan UOC Malattie Infettive Azienda Ospedaliera Universitaria Padova 16 years ago, in an editorial in the first issue of The Lancet Infectious
More informationThe pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens
The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens Cellular and Molecular Pharmacology Unit Catholic University of Louvain, Brussels,
More informationRETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR
Original article RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR R.Sujatha 1,Nidhi Pal 2, Deepak S 3 1. Professor & Head, Department
More informationManagement of hospital-acquired acquired pneumonia in the Asian Pacific region
Management of hospital-acquired acquired pneumonia in the Asian Pacific region Jae-Hoon Song, MD, PhD Samsung Medical Center Asian Network for Surveillance of Resistant Pathogens (ANSORP) Asian-Pacific
More informationANTIMICROBIAL STEWARDSHIP IN LONG TERM CARE FACILITIES
ANTIMICROBIAL STEWARDSHIP IN LONG TERM CARE FACILITIES ANTIMICROBIAL STEWARDSHIP COLLABORATIVE COLORADO HOSPITAL ASSOCIATION MARCH 23, 2016 Bridget Olson, RPh Infectious Disease Pharmacist, Sharp Coronado
More information2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services
2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens
More information